These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28864939)

  • 1. Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology.
    Dourmishev LA; Guleva DV; Miteva LG
    Wien Med Wochenschr; 2018 Jun; 168(9-10):213-217. PubMed ID: 28864939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intravenous immunoglobulin therapy of serious autoimmune rheumatic diseases.
    Lukan N; Lazurova I; Racz O; Kristofova B; Tkac I
    Bratisl Lek Listy; 2008; 109(11):489-92. PubMed ID: 19205557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
    Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
    Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous immunoglobulins for the treatment of dermatological autoimmune diseases.
    Hoffmann JHO; Enk AH
    J Dtsch Dermatol Ges; 2017 Dec; 15(12):1211-1226. PubMed ID: 29228499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin therapy for rheumatic diseases.
    Sany J
    Curr Opin Rheumatol; 1994 May; 6(3):305-10. PubMed ID: 8060767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulins in dermatology. Part 2: clinical indications and outcomes.
    Forbat E; Ali FR; Al-Niaimi F
    Clin Exp Dermatol; 2018 Aug; 43(6):659-666. PubMed ID: 29774587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.
    Steinbrecher A; Berlit P
    J Neurol; 2006 Sep; 253 Suppl 5():V39-49. PubMed ID: 16998753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of high-dose intravenous immunoglobulins in the therapy of connectivitis: preliminary experience in 5 cases].
    De Vita S; D'Ascanio A; Bombardieri S
    Recenti Prog Med; 1991 Nov; 82(11):603-6. PubMed ID: 1763234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous immunoglobulin (IVIG)].
    Hara M
    Nihon Rinsho; 2009 Mar; 67(3):599-605. PubMed ID: 19280939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses.
    Dourmishev LA; Guleva DV; Miteva LG
    Int J Inflam; 2016; 2016():3523057. PubMed ID: 26885437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease].
    Hiemstra I; Sanders EA; Tiddens HA
    Tijdschr Kindergeneeskd; 1991 Oct; 59(5):185-9. PubMed ID: 1957306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-threatening dermatoses due to connective tissue disorders.
    Katsambas A; Stefanaki C
    Clin Dermatol; 2005; 23(3):238-48. PubMed ID: 15896538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of the Use of Intravenous Immunoglobulin Therapy in Dermatology.
    Engel C; Holcomb ZE
    Skin Therapy Lett; 2024 May; 29(3):1-4. PubMed ID: 38781951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE).
    Goodfield M; Davison K; Bowden K
    J Dermatolog Treat; 2004 Jan; 15(1):46-50. PubMed ID: 14754650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic Spectrum of Connective Tissue Diseases Commonly Affecting the Skin.
    Laga AC; Larson A; Granter SR
    Surg Pathol Clin; 2017 Jun; 10(2):477-503. PubMed ID: 28477892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases.
    Ballow M
    Cancer; 1991 Sep; 68(6 Suppl):1430-6. PubMed ID: 1878841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009.
    Balin SJ; Wetter DA; Andersen LK; Davis MD
    Arch Dermatol; 2012 Apr; 148(4):455-62. PubMed ID: 22184719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid hormones; metabolic studies in dermatomyositis, lupus erythematosus and polymorphic light-sensitive eruptions.
    LAMB JH; LAIN ES
    Arch Derm Syphilol; 1948 May; 57(5):785-801. PubMed ID: 18888059
    [No Abstract]   [Full Text] [Related]  

  • 20. Musculoskeletal Manifestations of Non-RA Connective Tissue Diseases: Scleroderma, Systemic Lupus Erythematosus, Still's Disease, Dermatomyositis/Polymyositis, Sjögren's Syndrome, and Mixed Connective Tissue Disease.
    Jacques T; Sudoł-Szopińska I; Larkman N; O'Connor P; Cotten A
    Semin Musculoskelet Radiol; 2018 Apr; 22(2):166-179. PubMed ID: 29672805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.